The current position of hydrochlorothiazide among thiazide and thiazide-like diuretics
Authors:
Jiří Slíva
Authors‘ workplace:
Ústav farmakologie 3. LF UK, Praha
Published in:
Vnitř Lék 2018; 64(1): 83-85
Category:
Reviews
Overview
Thiazide and thiazide-like diuretics are an important group of drugs used in the treatment of essential arterial hypertension. While their beneficial therapeutic effect in monotherapy is evident, they are increasingly used in fixed combinations, particularly with ACE inhibitors or sartans. The aim of this article was to summarize the current status of hydrochlorothiazide and compare its effects with other substances in this subgroup of diuretics.
Key words:
diuretics – HCTZ – hydrochlorothiazide – hypertension – chlorthalidone – indapamide – thiazide
Sources
1. Elliott WJ, Weber RR, Murphy MB. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J Clin Pharmacol 1991; 31(8): 751–757.
2. Elisaf MS, Theodorou J, Pappas H et al. Effectiveness and metabolic effects of perindopril and diuretics combination in primary hypertension. J Hum Hypertens 1999; 13(11): 787–791.
3. Spence JD, Huff M, Barnett PA. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison. Can J Clin Pharmacol 2000; 7(1): 32–37.
4. Krum H, Skiba M, Gilbert RE. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy. Diabet Med 2003; 20(9): 708–712.
5. Roush GC, Ernst ME, Kostis JB et al. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension 2015; 65(5): 1041–1046. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.05021>.
6. Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension 2012; 59(6): 1110–1117. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.191106>.
7. Kaplan NM. Chlorthalidone versus hydrochlorothiazide: a tale of tortoises and a hare. Hypertension 2011; 58(6): 994–995. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.183525>.
8. Dhalla IA, Gomes T, Yao Z et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann Intern Med 2013; 158(6): 447–455. Dostupné z DOI: <http://dx.doi.org/10.7326/0003–4819–158–6-201303190–00004>.
9. Kreeft JH, Langlois S, Ogilvie RI. Comparative trial of indapamide and hydrochlorothiazide in essential hypertension, with forearm plethysmography. J Cardiovasc Pharmacol 1984; 6(4): 622–626.
10. Plante GE, Dessurault DL. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide. Am J Med 1988; 84(1B): 98–103.
11. Madkour H, Gadallah M, Riveline B et al. Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. Am J Nephrol 1995; 15(3): 251–255.
12. Emeriau JP, Knauf H, Pujadas JO et al. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study. J Hypertens 2001; 19(2): 343–350.
13. Semenkin AA, Zhivilova LA, Golevtsova ZS et al. Comparative assessment of hypotensive, metabolic, and endothelial effects of indapamide-retard and hydrochlorothiazide in patients with essential hypertension. Kardiologiia 2006; 46(5): 35–39.
14. Contard F, Glukhova M, Sabri A et al. Comparative effects of indapamide and hydrochlorothiazide on cardiac hypertrophy and vascular smooth-muscle phenotype in the stroke-prone, spontaneously hypertensive rat. J Cardiovasc Pharmacol 1993; 22(Suppl 6): S29-S34.
15. Rendu F, Bachelot C, Molle D et al. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide. J Cardiovasc Pharmacol 1993; 22(Suppl 6): S57-S63.
16. Vergely C, Walker MK, Zeller M et al. Antioxidant properties of indapamide, 5-OH indapamide and hydrochlorothiazide evaluated by oxygen-radical absorbing capacity and electron paramagnetic resonance. Mol Cell Biochem 1998; 178(1–2): 151–155.
17. Poulsen L, Friberg M, Noer I et al. Comparison of indapamide and hydrochlorothiazide plus amiloride as a third drug in the treatment of arterial hypertension. Cardiovasc Drugs Ther 1989; 3(2): 141–144.
18. Luccioni R, Sever PS, Di PT et al. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. J Hypertens 1995; 13(12 Pt 2): 1847–1851.
19. Cremonesi G, Cavalieri L, Cikes I et al. Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension. Adv Ther 2002; 19(3): 129–137.
20. Circelli M, Nicolini G, Egan CG et al. Efficacy and safety of delapril/indapamide compared to different ACE-inhibitor/hydrochlorothiazide combinations: a meta-analysis. Int J Gen Med 2012; 5: 725–734. Dostupné z DOI: <http://dx.doi.org/10.2147/IJGM.S35220>.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2018 Issue 1
Most read in this issue
- Familial combined hyperlipidemia – the most common genetic dyslipidemia in population and in patients with premature atherothrombotic cardiovascular disease
- Epidemiology of hypercholesterolemia
- Diabetic dyslipidemia and microvascular complications of diabetes
- The current position of hydrochlorothiazide among thiazide and thiazide-like diuretics